After years of delays Pfizer and Eli Lilly’s tanezumab non-opioid pain drug is edging closer to approval, after it met targets in an osteoarthritis trial. Tanezumab is a nerve growth factor (NGF ...

As MedSurg demand rises, Boston Scientific and Medtronic compete for dominance. Which stock shows stronger growth momentum now?

A team of doctors at Michigan Medicine have successfully treated a child in severe septic shock and multiorgan failure with ...

Accused in the shooting, which occurred one month after the brazen murder of the UnitedHealthcare CEO in New York City, was ...

Despite her best instincts, Charlie can’t help but get involved in an investigation into the dangers of gym culture.

Calamos Phineus Long/Short Fund rose 0.93% in Q1 (Class I shares at NAV), compared with a price decline of -4.27% for the S&P ...

Ready, set, save! Get a head start and score up to 50% off the hottest shoe brands during Amazon's early Prime Day deals.

A federal jury has awarded $500,000 to the widow and estate of a police officer who killed himself nine days after he helped ...

Background There is lack of evidence for specific treatment interventions for patients with non-specific chronic low back pain (NSCLBP) despite the substantial amount of randomised controlled clinical ...

Asian shares have logged modest gains after U.S. stocks climbed to near their all-time high as investors considered comments by Federal Reserve Chair Jerome Powell to Congress.

Men who've strangled women to death described their experiences to the Sarasota Herald-Tribune as a means of control in their ...